The hemostatic and inflammatory systems work hand in hand to maintain homeostasis at mucosal barrier sites. Among the factors of the hemostatic system, fibrin is well recognized for its role in mucosal homeostasis, wound healing, and inflammation. Here, we present a basic overview of the fibrinolytic system, discuss fibrin as an innate immune regulator, and provide recent work uncovering the role of fibrin–neutrophil activation as a regulator of mucosal/periodontal homeostasis. We reason that the role of fibrin in periodontitis becomes most evident in individuals with the Mendelian genetic defect, congenital plasminogen (PLG) deficiency, who are predisposed to severe periodontitis in childhood due to a defect in fibrinolysis. Consistent with plasminogen deficiency being a risk factor for periodontitis, recent genomics studies uncover genetic polymorphisms in PLG, encoding plasminogen, being significantly associated with periodontal disease, and suggesting PLG variants as candidate risk indicators for common forms of periodontitis.
AdamsRASchachtrupCDavalosDTsigelnyIAkassoglouK. 2007. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr Med Chem. 14(27): 2925–2936.
2.
AltieriDCBaderRMannucciPMEdgingtonTS. 1988. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol. 107(5):1893–1900.
3.
BaykulTBozkurtY. 2004. Destructive membranous periodontal disease (ligneous periodontitis): a case report and 3 years follow-up. Br Dent J. 197(8):467–468.
4.
BorelMG. 1933. A new palpebral syndrome (in french). Bull Soc Fr Ophthalmol46:168–180.
5.
BouissonM. 1847. Ophthalmie sur-aigue avec formation de pseudomembranes àla surface de la conjonctive. Ann Oculist. 17(1847):100–104.
6.
BuggeTHKombrinckKWFlickMJDaughertyCCDantonMJDegenJL. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 87(4):709–719.
7.
Cesarman-MausGHajjarKA. 2005. Molecular mechanisms of fibrinolysis. Br J Haematol. 129(3):307–321.
8.
ColeHAOhbaTNymanJSHirotakaHCatesJMFlickMJDegenJLSchoeneckerJG. 2014. Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Arthritis Rheumatol. 66(8):2222–2233.
9.
ColemanPLBarouskiPAGelehrterTD. 1982. The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation. J Biol Chem. 257(8):4260–4264.
10.
CollenDLijnenHR. 1992. Fibrin-specific fibrinolysis. Ann N Y Acad Sci. 667:259–271.
11.
CollenDLijnenHR. 1994. Fibrinolysis and the control of hemostasis. In: StamatoyannopoulosGNienhuisAWMajerusPWVarmusHE, editors. The molecular basis of blood diseases. Philadelphia (PA): WB Saunders Co. p. 725–752.
12.
CollenDWimanB. 1979. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood. 53(2):313–324.
13.
ConsortiumGT. 2020. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 369(6509):1318–1330.
14.
DegenJLBuggeTHGoguenJD. 2007. Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost. 5(Suppl 1):24–31.
15.
DiamondMSGarcia-AguilarJBickfordJKCorbiALSpringerTA. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol. 120(4):1031–1043.
16.
EsmonCT. 2005. The interactions between inflammation and coagulation. Br J Haematol. 131(4):417–430.
17.
EsmonCT. 2008. Crosstalk between inflammation and thrombosis. Maturitas. 61(1–2):122–131.
18.
FineGBauerKAl-MohayaMWooSB. 2009. Successful treatment of ligneous gingivitis with warfarin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 107(1):77–80.
19.
FlickMJDuXDegenJL. 2004. Fibrin(ogen)-αMβ2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood). 229(11):1105–1110.
20.
FlickMJDuXWitteDPJirouskovaMSolovievDABusuttilSJPlowEFDegenJL. 2004. Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 113(11):1596–1606.
21.
FlickMJLaJeunesseCMTalmageKEWitteDPPalumboJSPinkertonMDThorntonSDegenJL. 2007. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin αMβ2 binding motif. J Clin Invest. 117(11):3224–3235.
22.
GreenKAAlmholtKPlougMRonoBCastellinoFJJohnsenMBuggeTHRomerJLundLR. 2008. Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. J Invest Dermatol. 128(8):2092–2101.
HajishengallisGMoutsopoulosNM. 2014. Etiology of leukocyte adhesion deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response. Expert Rev Clin Immunol. 10(8):973–975.
KopecAKAbrahamsSRThorntonSPalumboJSMullinsESDivanovicSWeilerHOwensAP3rdMackmanNGossA, et al. 2017. Thrombin promotes diet-induced obesity through fibrin-driven inflammation. J Clin Invest. 127(8):3152–3166.
27.
KurtulusIGokbugetAEfeogluACintanSTefsKSchusterVScullyC. 2007. Hypoplasminogenemia with ligneous periodontitis: a failed local therapeutic approach. J Periodontol. 78(6):1164–1175.
28.
LawRHCaradoc-DaviesTCowiesonNHorvathAJQuekAJEncarnacaoJASteerDCowanAZhangQLuBG, et al. 2012. The x-ray crystal structure of full-length human plasminogen. Cell Rep. 1(3):185–190.
29.
LishkoVKKudrykBYakubenkoVPYeeVCUgarovaTP. 2002. Regulated unmasking of the cryptic binding site for integrin αMβ2 in the gamma c-domain of fibrinogen. Biochemistry. 41(43):12942–12951.
30.
LishkoVKYakubenkoVPHertzbergKMGrieningerGUgarovaTP. 2001. The alternatively spliced αEC domain of human fibrinogen-420 is a novel ligand for leukocyte integrins αMβ2 and αXβ2. Blood. 98(8):2448–2455.
31.
LoskutoffDJvan MourikJAEricksonLALawrenceD. 1983. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci U S A. 80(10):2956–2960.
32.
LuyendykJPSchoeneckerJGFlickMJ. 2019. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 133(6):511–520.
MingersAMHeimburgerNLutzE. 1995. Familial homozygous and heterozygous type I plasminogen deficiency [in German]. In: ScharrerISchrammW, editors. Haemophilie Symposium, Hamburg, 1994. Berlin: Springer-Verlag. p. 96–104.
35.
MingersAMHeimburgerNZeitlerPKrethHWSchusterV. 1997. Homozygous type I plasminogen deficiency. Semin Thromb Hemost. 23(3):259–269.
36.
MoutsopoulosNMKonkelJSarmadiMEskanMAWildTDutzanNAbuslemeLZenobiaCHosurKBAbeT, et al. 2014. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med. 6(229):229ra240.
37.
MullerRFreitag-WolfSWeinerJ3rdChopraATopTDommischHSchaeferAS. 2023. Case-only design identifies interactions of genetic risk variants at SIGLEC5 and PLG with the lncRNA CTD-2353f22.1 implying the importance of periodontal wound healing for disease aetiology. J Clin Periodontol. 50(1):90–101.
38.
MunzMRichterGMLoosBGJepsenSDivarisKOffenbacherSTeumerAHoltfreterBKocherTBruckmannC, et al. 2019. Meta-analysis of genome-wide association studies of aggressive and chronic periodontitis identifies two novel risk loci. Eur J Hum Genet. 27(1):102–113.
39.
NesheimMBajzarL. 2005. The discovery of TAFI. J Thromb Haemost. 3(10):2139–2146.
40.
NibaliLBayliss-ChapmanJAlmofarehSAZhouYDivarisKVieiraAR. 2019. What is the heritability of periodontitis? A systematic review. J Dent Res. 98(6):632–641.
41.
OkamotoASakataTMannamiTBabaSKatayamaYMatsuoHYasakaMMinematsuKTomoikeHMiyataT. 2003. Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: the Suita Study. J Thromb Haemost. 1(11):2397–2403.
42.
PantanowitzLBauerKTefsKSchusterVBaloghKPilchBZAdcockDCirovicCKocherO. 2004. Ligneous (pseudomembranous) inflammation involving the female genital tract associated with type-1 plasminogen deficiency. Int J Gynecol Pathol. 23(3):292–295.
43.
PierroVSVazquez-SullcaRVieiraASTakiyaCMCarakushanskyGFeres-FilhoEJ. 2006. Ligneous periodontitis and Ehlers-Danlos syndrome. J Periodontol. 77(1):123–128.
44.
SchusterVMingersAMSeidenspinnerSNussgensZPukropTKrethHW. 1997. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood. 90(3):958–966.
ScullyCGokbugetAKurtulusI. 2007. Hypoplasminogenaemia, gingival swelling and ulceration. Oral Dis. 13(6):515–518.
47.
ScullyCGokbugetAYAllenCBaganJVEfeogluAErsevenGFlaitzCCintanSHodgsonTPorterSR, et al. 2001. Oral lesions indicative of plasminogen deficiency (hypoplasminogenemia). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 91(3):334–337.
48.
ShunginDHaworthSDivarisKAglerCSKamataniYKeun LeeMGrindeKHindyGAlaraudanjokiVPesonenP, et al. 2019. Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data. Nat Commun. 10(1):2773.
49.
SilvaLMBrenchleyLMoutsopoulosNM. 2019. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis. Immunol Rev. 287(1):226–235.
50.
SilvaLMDoyleADGreenwell-WildTDutzanNTranCLAbuslemeLJuangLJLeungJChunEMLumAG, et al. 2021. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 374(6575):eabl5450.
51.
SilvaLMLumAGTranCShawMWGaoZFlickMJMoutsopoulosNMBuggeTHMullinsES. 2019. Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation. Blood. 134(3):291–303.
52.
SteinbrecherKAHorowitzNABlevinsEABarneyKAShawMAHarmel-LawsEFinkelmanFDFlickMJPinkertonMDTalmageKE, et al. 2010. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin αMβ2 engagement of fibrinogen. Cancer Res. 70(7):2634–2643.
53.
SulniuteRLindhTWilczynskaMLiJNyT. 2011. Plasmin is essential in preventing periodontitis in mice. Am J Pathol. 179(2):819–828.
54.
TefsKGueorguievaMKlammtJAllenCMAktasDAnlarFYAydogduSDBrownDCiftciEContariniP, et al. 2006. Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients. Blood. 108(9):3021–3026.
55.
TefsKGeorgievaMSeregardSTaitCRLuchtman-JonesLZieglerMHugleBSchusterV. 2004. Characterization of plasminogen variants in healthy subjects and plasminogen mutants in patients with inherited plasminogen deficiency by isoelectric focusing gel electrophoresis. Thromb Haemost. 92(2):352–357.
56.
UgarovaTPLishkoVKPodolnikovaNPOkumuraNMerkulovSMYakubenkoVPYeeVCLordSTHaasTA. 2003. Sequence γ377-395(P2), but not γ190-202(P1), is the binding site for the αMI-domain of integrin αMβ2 in the γC-domain of fibrinogen. Biochemistry. 42(31):9365–9373.
57.
UgarovaTPSolovjovDAZhangLLoukinovDIYeeVCMedvedLVPlowEF. 1998. Identification of a novel recognition sequence for integrin αMβ2 within the γ-chain of fibrinogen. J Biol Chem. 273(35):22519–22527.
58.
UgarovaTPYakubenkoVP. 2001. Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci. 936:368–385.
59.
VidalBSerranoALTjwaMSuelvesMArditeEDe MoriRBaeza-RajaBMartinez de LagranMLafustePRuiz-BonillaV, et al. 2008. Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway. Genes Dev. 22(13):1747–1752.
60.
WrightSDWeitzJIHuangAJLevinSMSilversteinSCLoikeJD. 1988. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A. 85(20):7734–7738.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
